Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Fauser

Showing results (221-230 of 237) with videos related to

Pageof 24
Sort By:
Ophthalmology|July 28, 2020
Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK ConsortiumAnita de Breuk, Ilhan E Acar, Eveline Kersten, et al.
Ebiomedicine|December 23, 2017
HtrA1 Mediated Intracellular Effects on Tubulin Using a Polarized RPE Disease ModelEsther Melo, Philipp Oertle, Carolyn Trepp, et al.
Clinical & Translational Immunology|December 15, 2020
Quantitative multiplex profiling of the complement system to diagnose complement-mediated diseasesEsther Willems, Laura Lorés-Motta, Andrea Zanichelli, et al.
Frontiers in Pharmacology|July 29, 2024
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal modelsUwe Grether, Richard H Foxton, Sabine Gruener, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Structural dynamics insights into principles underlying the fitness of new broadly potent AAVsMolly E Johnson, Bilge E Ozturk, Thomas H Tugwell, et al.
Nature Genetics|May 21, 2013
A functional variant in the CFI gene confers a high risk of age-related macular degenerationJohannes P H van de Ven, Sara C Nilsson, Perciliz L Tan, et al.
European Journal of Epidemiology|December 22, 2015
Ophthalmic epidemiology in Europe: the "European Eye Epidemiology" (E3) consortiumCécile Delcourt, Jean-François Korobelnik, Gabriëlle H S Buitendijk, et al.
JAMA Ophthalmology|June 1, 2018
Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular DegenerationLaura Lorés-Motta, Moeen Riaz, Michelle Grunin, et al.
Ophthalmology|October 14, 2018
Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology ConsortiaJohanna M Colijn, Anneke I den Hollander, Ayse Demirkan, et al.
Nature Genetics|September 17, 2013
A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degenerationHannes Helgason, Patrick Sulem, Maheswara R Duvvari, et al.
Pageof 24

Showing results (221-230 of 237) with videos related to

Sort By:
Pageof 24
Ophthalmology|July 28, 2020
Development of a Genotype Assay for Age-Related Macular Degeneration: The EYE-RISK ConsortiumAnita de Breuk, Ilhan E Acar, Eveline Kersten, et al.
Ebiomedicine|December 23, 2017
HtrA1 Mediated Intracellular Effects on Tubulin Using a Polarized RPE Disease ModelEsther Melo, Philipp Oertle, Carolyn Trepp, et al.
Clinical & Translational Immunology|December 15, 2020
Quantitative multiplex profiling of the complement system to diagnose complement-mediated diseasesEsther Willems, Laura Lorés-Motta, Andrea Zanichelli, et al.
Frontiers in Pharmacology|July 29, 2024
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal modelsUwe Grether, Richard H Foxton, Sabine Gruener, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Structural dynamics insights into principles underlying the fitness of new broadly potent AAVsMolly E Johnson, Bilge E Ozturk, Thomas H Tugwell, et al.
Nature Genetics|May 21, 2013
A functional variant in the CFI gene confers a high risk of age-related macular degenerationJohannes P H van de Ven, Sara C Nilsson, Perciliz L Tan, et al.
European Journal of Epidemiology|December 22, 2015
Ophthalmic epidemiology in Europe: the "European Eye Epidemiology" (E3) consortiumCécile Delcourt, Jean-François Korobelnik, Gabriëlle H S Buitendijk, et al.
JAMA Ophthalmology|June 1, 2018
Association of Genetic Variants With Response to Anti-Vascular Endothelial Growth Factor Therapy in Age-Related Macular DegenerationLaura Lorés-Motta, Moeen Riaz, Michelle Grunin, et al.
Ophthalmology|October 14, 2018
Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology ConsortiaJohanna M Colijn, Anneke I den Hollander, Ayse Demirkan, et al.
Nature Genetics|September 17, 2013
A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degenerationHannes Helgason, Patrick Sulem, Maheswara R Duvvari, et al.
Pageof 24